<DOC>
	<DOCNO>NCT00852826</DOCNO>
	<brief_summary>This study intend assess value hemostatic sealing agent , collagen sponge coat human coagulation factor ( fibrinogen thrombin ) ( TachoSilÂ® ) , decrease occurrence seroma axillary lymphadenectomy .</brief_summary>
	<brief_title>Evaluation Hemostatic Sealing Agent Prevent Surgical Complications After Axillary Lymphadenectomy</brief_title>
	<detailed_description />
	<mesh_term>Seroma</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Patients axillary lymphadenectomies perform oncological condition . Patients want participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>axillary seroma</keyword>
	<keyword>axillary lymphadenectomy</keyword>
	<keyword>morbidity</keyword>
	<keyword>morbidity postlymphadenectomy</keyword>
	<keyword>Lymphadenectomy</keyword>
</DOC>